Specialized Hospital For Active Treatment Of Childrens Diseases Professor Ivan Mitev — Clinical Trial Site

13 Registered trials

8 Currently recruiting

Organisation

Specialized Hospital For Active Treatment Of Childrens Diseases Professor Ivan Mitev

Location

Sofia, Bulgaria

Identifier

ORG-100031701

Address

Academician Ivan Geshov Blvd 11, 1606, Bulgaria

Departments

Clinic of Chidren Gastroenterology
Clinic of children neurology - nervous diseases
Clinic of Children’s Gastroenterology
Clinic of pediatric endocrinology and metabolic diseases
Clinic of Pediatric Nephrology and Dialysis – dialysis treatment
Clinic of Pediatric Nephrology and Hemodialysis
Clinic of Pediatric Rheumatology
N/A
NA

Clinical trials at this site (13)

Search interface

A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending

2023-509176-42-00 Obesity and T2D 11
Safety, tolerability, pharmacokinetics, and efficacy of filgotinib for the treatment of polyarticular-course juvenile idiopathic arthritis i… Recruiting

2024-511593-70-00 Polyarticular-course juvenile idiopathic arthritis 5 2026-04-27
Vedolizumab Subcutaneous Long-term Open-label Extension Study in Pediatric Subjects Recruiting

2023-508804-39-00 Ulcerative Colitis or Crohn’s Disease 5 2025-10-15
Efficacy and Safety Study of Once-Daily Extended-Release Levetiracetam in Drug-resistant Focal Onset Seizures Recruiting

2024-514499-42-00 Refractory Partial Onset Epilepsy 5 2025-03-12
Phase 3 Study of Vedolizumab Subcutaneous in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Recruiting

2023-503188-40-00 Active Ulcerative Colitis or Crohn’s Disease 5 2025-01-06
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects with Moderately to Severely Active Crohn's Dis… Recruiting

2023-509618-12-00 Crohn's Disease (CD) 5 2024-09-11
Crohn's Disease: Pharmacokinetics, Efficacy, and Safety of Risankizumab in Pediatric Subjects with Moderately to Severely Active Crohn's Dis… Recruiting

2022-502050-14-00 Crohn's disease 5 2024-06-04
A Phase 3, Open-Label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Trea… Recruiting

2022-501980-42-00 Anemia associated with Chronic Kidney Disease 5 2023-12-21
A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece… Recruiting

2023-504885-50-00 Treatment of children with chronic kidney disease and p 5 2022-11-07
A research study to compare somapacitan once a week with Norditropin® once a day in children who need help to grow Ended

2023-506927-27-00 Children with short stature either born small for gesta 5 2022-08-29
A study to learn how well finerenone works; how safe it is; how it moves into, through, and out of the body; and the effects it has on the b… Ended

2023-504884-17-00 Proteinuria 5 2022-02-04
Functional Constipation: Linaclotide versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, with Functional Constipation (FC) Ended

2022-501946-31-00 Functional Constipation 5 2024-02-29
Functional Constipation: A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Le… Ended

2022-501947-34-00 Functional Constipation (FC) 4 2023-12-05